Surgical Consent During the COVID-19 Pandemic

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Consent Clinical Trial

Official title:
Consent for Surgery During the COVID-19 Pandemic

Status Completed

Clinical Trial Summary

Multiloop audit of consenting practice in surgical procedures during the COVID-19 pandemic

n/a

See also
Status	Clinical Trial	Phase
Completed	`NCT04852016` - Optimizing the Consent Process for Emergent Laparoscopic Cholecystectomy	N/A
Recruiting	`NCT05880147` - App-based Consent for Pediatric Clinical Research	N/A
Recruiting	`NCT04953169` - Examining Health Literacy in Biorepository Consents	N/A
Active, not recruiting	`NCT04613505` - Determining Parental Attitudes Toward Day of Surgery Consent for Research
Completed	`NCT03677219` - Lumbar Puncture Video Study	N/A